TAO Synergies (TAOX) Preferred Dividend Payments (2023 - 2026)
TAO Synergies' (TAOX) quarterly Preferred Dividend Payments came in at $201045.0 in Q2 2026, up 95.69% on a YoY basis from $102739.0 in Q2 2025, and down 1.15% quarter-over-quarter from $203384.0 in Q1 2026.
Analysis
TAO Synergies (TAOX) Preferred Dividend Payments (2023 - 2026) Analysis & Trends
TAO Synergies (TAOX) has reported Preferred Dividend Payments for 4 consecutive years, with $201045.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Preferred Dividend Payments rose 95.69% year-over-year to $201045.0; the trailing twelve-month figure through Jun 2026 stood at $538646.0 (down 13.1% YoY), and the FY2025 full-year result was $338359.0, down 57.16% from the prior year.
- Preferred Dividend Payments eased to $201045.0 in Q2 2026 per TAOX's latest filing, from $203384.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $1.1 million in Q3 2023 and bottomed at $45210.0 in Q3 2025.
- Historically, Preferred Dividend Payments has averaged $255747.9 across 4 years, with a median of $202214.5 in 2026.
- The sharpest annual moves came in 2025 and 2026: Preferred Dividend Payments sank 85.26% in 2025, then surged 100.57% in 2026.
- Over 4 years, Preferred Dividend Payments stood at $233497.0 in 2023, then slumped by 53.32% to $108990.0 in 2024, then dropped by 18.33% to $89007.0 in 2025, then soared by 125.88% to $201045.0 in 2026.
- According to Business Quant data, Preferred Dividend Payments over the past three periods registered $201045.0, $203384.0, and $89007.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.35 Bn | 198.36 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 181.19 Bn | 178.01 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.48 Bn | 124.62 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.59 Bn | 74.60 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 61.45 Bn | 56.27 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.89 Bn | 49.75 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.21 Bn | 30.90 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.38 Bn | 30.10 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.81 Bn | 29.81 Bn | 1.16 Mn | - |
| 10 | TAO Synergies | 30.41 Mn | 30.41 Mn | - | 201,045.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 201,045.00 |
| Mar 31, 2026 | 203,384.00 |
| Dec 31, 2025 | 89,007.00 |
| Sep 30, 2025 | 45,210.00 |
| Jun 30, 2025 | 102,739.00 |
| Mar 31, 2025 | 101,403.00 |
| Dec 31, 2024 | 108,990.00 |
| Sep 30, 2024 | 306,725.00 |
| Jun 30, 2024 | 155,735.00 |
| Mar 31, 2024 | 218,459.00 |
| Dec 31, 2023 | 233,497.00 |
| Sep 30, 2023 | 1.12 Mn |
| Jun 30, 2023 | 423,575.00 |
| Mar 31, 2023 | 266,074.00 |